Clues Hidden in the Skin

Update Item Information
Identifier walsh_2013_s3_c4
Title Clues Hidden in the Skin
Creator Janet C. Rucker; Catherine Cho; James Weisfeld-Adams; Scott Brodie
Affiliation (JCR) (CC) Mount Sinai/Neurology, New York, NY; (JCR) (SB) Mount Sinai/Ophthalmology, New York, NY; (JW) Mount Sinai/Genetics, New York, NY
Subject Chediak-Higashi Syndrome; Optic Neuropathy; Parkinsonism; Spinocerebellar degeneration
Description The patient had multifocal neurological illness with optic nerve, spinocerebellar, extrapyramidal, and neuromuscular involvement. Brain MRI showed cortical atrophy. Cervical spine MRI was normal. EMG revealed axonal polyneuropathy. Electroretinogram was normal. Skin biopsy showed lymphocyte intracellular inclusions and amyloid deposition. Lymphocyte panel revealed low natural killer cell activity. Light microscopy of hair shaft showed pigmentary clumping. Normal labs included CK, cryoglobulins, HTLV-1 and 2, SCA 1-3 and 6, OPA-1. VEP was extinguished (age 43). Genetic testing diagnosed Chediak-Higashi Syndrome (CHS). SNP array showed no loss of heterozygosity, suggesting no close parental relationship. Sequencing of the entire coding region of LYST identified homozygosity for a novel six base pair in-frame deletion in exon 43, predicting the loss of asparagine and threonine residues from the LYST protein product. The proband was also heterozygous for an intronic sequence variant distal to the deletion. Homozygosity was confirmed in both affected brothers and both parents. Unaffected brothers were confirmed heterozygotes. Mutations in LYST, a ubiquitously expressed gene concerned with lysosomal trafficking, cause CHS. It is an autosomal recessive disorder characterized by childhood-onset immune dysfunction and hemophagocytic syndrome, partial oculocutaneous albinism and other pigmentary abnormalities, and neurologic dysfunction. Amyloidosis, as in this case, is reported in CHS and may contribute to the neurodegenerative process. Rare CHS patients, such as ours, present with absent or subclinical immunological abnormalities, but develop progressive neurodegenerative disease in early adulthood. Oculocutaneous albinism is characteristic, but was absent in our patient and in other reported cases. There is one case of visual dysfunction in CHS with an extinguished ERG. To our knowledge, optic nerve involvement has not been reported in CHS. Vision loss progressed over two years, with acuity at age 43 of 20/80 OD and 20/100 OS with complete loss of color vision. Both homozygous brothers had bilateral optic nerve involvement.
History She underwent neurological evaluation at age 32 (neuroimaging, serologies, lumbar puncture, muscle biopsy) with no resultant diagnosis (records unavailable). She required a wheelchair by age 36 and gradually developed slurred speech, cognitive decline, and worsened motor function. Simultaneous with neurologic evaluation, she was undergoing dermatologic evaluation for generalized hyperpigmentation with hypopigmented macules.
Pathology Skin biopsy showed lymphocyte intracellular inclusions and amyloid deposition. Lymphocyte panel revealed low natural killer cell activity. Light microscopy of hair shaft showed pigmentary clumping. Normal labs included CK, cryoglobulins, HTLV-1 and 2, SCA 1-3 and 6, OPA-1. VEP was extinguished (age 43). Genetic testing diagnosed Chediak-Higashi Syndrome (CHS).
Disease/Diagnosis Chediak-Higashi Syndrome (with an adult-onset neurodegenerative phenotype).
Clinical Neurological examination revealed pseudobulbar affect, perseveration, hypophonia, dysarthric speech, proximal greater than distal and leg greater than arm weakness, decreased vibratory and pinprick sensation in legs, hypereflexia with upgoing toes, frontal lobe reflexes, upper extremity dysmetria, and hypotonia. Acuity was 20/25 OD and 20/30 OS. Color vision (Ishihara) was control only OD and 2/14 OS. Contrast sensitivity (Peli-Robson) was reduced (line 4OD, 5 OS). There was no APD. Optic discs were mildly pale temporally. Goldmann field revealed complete central vision loss to small isopters. Ocular motor exam was normal except for hypermetric saccades.
Presenting Symptom A 40-year old woman, neurologically normal until age 31, presented with progressive paraparesis over several years.
Neuroimaging MRI; EMG
Date 2013-02
References 1. Maeda K, Sueishi K, Fukai K, et al. A case report of Chediak-Higashi syndrome complicated with systemic amyloidosis and olivocerebellar degeneration. Path Res Pract 1989;185:231-237. 2. Nagle DL, Karim MA. Woolf EA, et al. Identification and mutation analysis of the complete gene for Cheidak-Higashi syndrome. Nat Genet 1996;14:307-311. 3. Rudelius M, Osanger A, Kohlmann S, et al. A missense mutation in the WD40 domain of murine Lyst kinked to severe progressive Purkinje cell degeneration. Acta Neuropathol 2006;112:267-276. 4. Sheramata W, Kott SK, Cr DP. The Chediak-Higashi-Steinbrinck syndrome: presentation of three cases with features resembling spinocerebellar degeneration. Arch Neurol 1974;25:289-294. 5. Tardieu M, Lacroix C, Neven B, et al. Progressive neurologic dysfunction 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood 2005;106:40-42.
Language eng
Format video/mp4
Type Image/MovingImage
Source 45th Annual Frank Walsh Society Meeting
Relation is Part of NANOS Annual Meeting 2013
Collection Neuro-Ophthalmology Virtual Education Library: Walsh Session Annual Meeting Archives: https://novel.utah.edu/Walsh/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6836pmn
Setname ehsl_novel_fbw
ID 179242
Reference URL https://collections.lib.utah.edu/ark:/87278/s6836pmn
Back to Search Results